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ABSTRACT
Protozoa of the Class Kinetoplastida include clinically-relevant pathogens such as
Leishmania and Trypanosoma. Although specific mechanisms or biological significance of
programmed cell death (PCD) have yet to be established in these organisms, morphological and
biochemical characteristics similar to mammalian PCD have been observed when triggered by
various stressors. Crithidia fasciculata is a trypanosomatid that does not infect humans and is a
model for studying cell death pathways. This study identifies orthologous proteins potentially
involved in PCD in C. fasciculata and clinically-relevant species. Oxidative stress, thermal
stress, rotenone, and starvation were used to induce PCD-like processes. Morphological and
nuclear features were assessed by fluorescent microscopy with annexin-V, Hoechst, and
propidium iodide. Oncosis-like and apoptosis-like features emerged following cellular stress.
Additionally, monodansylcadaverine staining of vacuoles suggests autophagic processes occur.
The results establish that cell death pathways in C. fasciculata share features with but are distinct
from mammalian PCD.
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1.1

INTRODUCTION

Trypanosomatids
1.1.1

Trypanosomatids, a global burden

The Family Trypanosomatidae is comprised of exclusively parasitic species that
frequently infect insects (1). Although the majority of the species are monoxenous and infect
only a single host species during their life-cycles, some trypanosomatids are dixenous and have
secondary hosts including mammals and plants (2). Arguably the most relevant dixenous
trypanosomatid species for human health are pathogens belonging to the genera Leishmania and
Trypanosoma.
Leishmania spp. are responsible for leishmaniasis and are widespread among tropical
and subtropical regions. They are found in nearly 100 countries in Africa, Asia, Europe, North
America, and South America (3). Leishmaniasis is considered by the World Health Organization
(WHO) to be one of seven most important tropical diseases, affecting more than 12 million
people, and placing more than 350 million at risk. These parasites are transmitted via bites of
phlebotomine sand flies and cause various clinical forms of the disease in humans (4,5).
Depending on the species of infection, leishmaniasis can range from mild dermatologic
discomfort to fatality (6). For example, L. major and L. mexicana cause cutaneous leishmaniasis
(CL) while L. donovani and L. infantum species can cause visceral leishmaniasis (VL) (7).
Cutaneous leishmaniasis is the most common form of the disease and affects 600,000 to 1
million people a year (8). Although CL does not lead to death, it is characterized by localized
ulcers that oftentimes result in scarring and social stigma (9). Visceral leishmaniasis is the most
severe clinical manifestation, resulting in more than 40,000 deaths annually (10). It is
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characterized by hepatomegaly, splenomegaly, lymphadenopathy, anemia, leukopenia,
thrombocytopenia, fever, and other systemic symptoms (11). Management of the disease
depends on species and clinical presentation. Treatment of CL can include topical, oral,
systemic, therapy, photo, and laser therapy. There, is however, no established regimen, and
evidence of the effectiveness of these therapies are limited and patient-specific (12,13).
Treatment of VL involves antiparasitic and antifungal drugs. Drug toxicities, cost, and drug
resistance are notable limitations (14-16).
Trypanosoma cruzi, the etiological agent for American trypanosomiasis (Chagas’
disease), is endemic to about 20 Latin American countries (17). Transmission of the parasite is
most commonly via bite of the vector “kissing bugs”. It is also spread by blood transfusion and
ingestion of contaminated foods (18). Collectively, the disease affects 6 to 8 million people
worldwide, puts up to 100 million at risk, and is responsible for approximately 50,000 deaths
annually (19,20). Trypanosomiasis is characterized by two successive phases: the high
parasitemia-associated acute phase that clinically presents asymptomatically or with anorexia
and fever, and the chronic phase that manifests with progressive digestive, cardiac, and
neurologic complaints (21). Acute phase disease can be cured in 50-80% of patients with
effective early action (22). Unlike leishmaniasis, trypanosomiasis that progresses to the chronic
phase is asymptomatic for the majority of cases (23). Of these cases, up to 40% develop
digestive, cardiac, or neurologic issues after 10 to 30 years (24). Severe cases of chronic phase
disease can involve advanced chronic heart disease and cardiomyopathy in which the only
treatment course is heart transplantation (25). Treatment of trypanosomiasis involves
antiparasitic drug therapy for acute phase disease and symptomatic care for chronic phase
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disease (26). Available antiparasitic drugs pose serious side effects and frequently are
discontinued during the treatment course (21,27).
Trypanosoma brucei, the etiological agent for human African trypanosomiasis (HAT, or
sleeping sickness), is endemic to about 35 sub-Saharan African countries and is transmitted via
the bite of tsetse flies (28). Approximately 11,000 people are infected with T. brucei with an
additional 70 million individuals at risk and, as of 2016, about 2,000 new cases annually (29-31).
Similar to Chagas’ disease, HAT evolves through two clinically distinct phases. The first stage
begins after a bite that is often accompanied by localized dermatologic symptoms and is
followed by intermittent fevers and a combination of lymphatic, endocrine, hepatic, splenic, and
cardiac symptoms as parasitemia develops (32,33). The second stage ensues after a few weeks
post-infection, when the parasite crosses the blood-brain barrier and invades the central nervous
system. This stage is characterized by encephalopathy, headaches, altered mental status and
eventually results in a somnolent mental state (33,34). If untreated or mismanaged, the infection
is eventually fatal (35). The first stage of HAT is managed well with pharmacologic therapy,
albeit with mild toxicity and side effects (32,36). The only treatment of the second stage of
infection is an intravenous drug that is considered painful and highly toxic with risk of serious
complications and 5-9% post-treatment fatalities (32,36).
Leishmaniasis, trypanosomiasis, and African sleeping sickness are all classified as
neglected tropical diseases given the paucity of financial support despite the overwhelming
public health burden and poor health outcomes faced by underserved, low-income, and rural
regions (11). Despite extensive research efforts globally to better understand trypanosome
biology, the arsenal of tools for diagnostics and treatment remains unfortunately limited. Critical
research advances including improved in vitro cultivation, whole-genome sequencing, and tools
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for genetic modification within the last few decades are being leveraged to better study parasite
and vector biology. Additional efforts towards expanding translational and pre-clinical
applications continue to be warranted (37-40).
1.1.2

Trypanosomatid biology

Trypanosomatids are organisms with unique organelles and physiology. They use a single
anterior flagellum to propel themselves in corkscrew-like motions. They possess a single, large
mitochondrion that has different morphologies based on life stages (41). For example, T. brucei
can have mitochondrion that feature abundant cristae and interconnecting networks of branches
that undergo fission and fusion processes. On the other hand, the mitchondrion can be much
simpler with unbranched tubules and few cristae (42). The complexity of the organelle is directly
related to cellular function. The insect forms of trypanosomatids possess enlarged cristae and
elaborate mitochondrial networks, reflecting the necessity for high aerobic respiration rates (43).
In contrast, blood stream T. brucei derive energy from glucose in the host blood and produce
ATP by substrate level phosphorylation. As such, the mitochondrion is simpler (44,45).
Belonging to the Class Kinetoplastida, trypanosomatids are all characterized by
kinetoplasts, a disk shaped “mitochondrial nucleoid” located in the mitochondrion at the base of
flagellum that is essentially a network of genetic material termed kinetoplast-DNA (kDNA). The
kDNA network is comprised of a few dozen maxicircles and thousands of minicircles, both of
which are interlocking circles of DNA of about 20 kb and 1 kb, respectively (46,47). These
encode important mitochondrial genes, including ribosomal RNA and respiratory complex
subunits (46). Furthermore, replication of the kDNA is an essential part of the cell cycle and is
initiated in G1, prior to nuclear replication (48).
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During each phase of their life cycle, these parasites differentiate to various
morphological forms, adapting to their environment. For example, while in the human host, T.
brucei exhibit slender forms with special coats that evade the host immune response. They then
differentiate to stumpy forms that promote transmission to their insect hosts upon bloodmeal of
the mammalian host. Once the parasites have entered the insect gut, they again change into
another form with another distinctive cellular coating that allows for adherence. Finally, they
migrate to the salivary glands and proliferate and develop the original special coating in
preparation for transmission into the human host (49,50). Each life cycle stage is also
characterized by the position of the kinetoplast, which shifts to a specific region in the cell
depending on the stage. Although the specific reason for the positioning of the kinetoplast is
unknown, it is understood that it is required for the progression of cell division, as it is
synchronous with nuclear replication (50).
1.1.3

Crithidia fasciculata as a model organism

Crithidia are monoxenous trypanosomatids that infect a broad range of insects and are
non-pathogenic to humans. Crithidia fasciculata infect mosquitoes and be found on flowers and
fruit, or in water after being voided with feces by infected insects (51). The parasite has two life
stages: the amastigote and choanomastigote (52). Amastigotes are non-motile, round cells with a
short flagellum and infect mosquitoes when the insects feed on nectar (52). C. fasciculata
adheres to the mosquito gut and differentiates into choanimastigotes. Choanimastigotes are
stumpy, free-swimming cells with long flagellum. After colonizing the mosquito gut,
choanimastigotes differentiate to amastigotes.
Choanimastigotes are further divided into two developmental forms, the non-motile
haptomonad and the swimming nectomonad. Haptomonads are rounder and have shortened

6
flagellum used to adhere to the mosquito hindgut and rectal papillae (53). These adherent cells
undergo cell division and form large clusters called “rosettes”. Eventually, cells break free from
the rosette and develop into nectomonads (54). Brooker (1971) discovered that both nectomonad
and haptomonad forms of C. fasciculata can be cultivated in vitro and that haptomonads attach to
artificial surfaces such as cellulose esters and polystyrene (55).
Crithidia fasciculata has been investigated as a model organism for human pathogenic
kinetoplastids because the species is not a threat to human health, is easily cultivated in scalable
quantities, and is genetically tractable (56). Though the release of the C. fasciculata genome has
been published (Stephen Beverely, Washington University School of Medicine), the key
molecular players in various biological functions remain largely unexplored (57). Genetically, L.
major, T. brucei, T. cruzi, and C. fasciculata share 6,000 orthologous genes (38).
Physiologically, these parasites share many traits including the flagellar attachment and rosette
formation of haptomonads, kinetoplast biology and mechanisms, and mitochondrial architecture,
biogenesis, and biology (54,58,59).
1.2

Regulated Cell death
Programmed or regulated cell death (PCD, RCD, cell suicide) are cellular pathways

defined by a series of molecular events that lead to organized cell demise. The scientific
discovery of apoptosis, the first defined pathway, marked the beginning of the era dedicated to
investigation of RCD. Schweichel et al. (60) classified RCD into three distinct categories based
on morphological profiles . The first was apoptosis, which was characterized by shrinkage of the
cell, formation of apoptotic bodies, membrane blebbing, chromatin digestion, and DNA
fragmentation. The second was autophagy-related cell death, characterized by autophagic
vacuolization of cytosol and organelles. The third was necrosis, characterized by membrane
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rupture, swelling of the cell, and swelling of organelles. Since then, there has been a plethora of
scientific work performed to better understand these cell death pathways as well as the discovery
of multiple other unique pathways. This section provides a brief overview of various PCD
pathways, associated morphological characteristics, and molecular machinery of these.
1.2.1

Autophagy

Autophagy is a regulated cell process that provides nutrients to maintain vital functions in
response to stressful conditions such as nutrient deprivation and hypoxia (61). Although
autophagy has homeostatic functionality, it is also recognized as a regulated cell death pathway.
Initially, autophagic cell death (ACD) described cells that showed evidence of autophagy during
cell death however recently ACD implicates the mechanistic decision-making that leads to cell
death (62,63). Autophagy’s association with PCD is however constantly questioned, particularly
its role as a true causative factor, whether it is an effect on PCD, or if it solely just a survival
mechanism during PCD (64). It is also complicated by evidence that autophagy can activate
other cell death pathways such as apoptosis and necroptosis.
Autophagic cell death, death that is dependent of autophagic machinery and without
involvement of other cell death processes, is characterized as sequestration of the cytoplasm and
its contents by structures termed autophagosomes that become fused with and degraded by
lysosomes (65,66). Morphologically, ACD is characterized uniquely by accumulation of
autophagosomes and autophagic vacuolization (67). It can also share morphological
characteristics with other RCD such as plasma membrane rupture, minor changes to the nucleus
and chromatin, and enlargement of other organelles such as the mitochondria (67).
Autophagy begins with formation of autophagosomes and proceeds ultimately to fusion
of autophagosomes with lysosomal compartments. This is a complex process and involves over
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30, autophagy-related genes (ATG) (68). The TORC1 complex (TORC1-Atg13) inhibits
autophagic induction and is inactivated by starvation (and other stressors). The Atg1/ULK
complex (Atg1-Atg11-Atg13-Atg17-Atg29-Atg-31) regulates induction of autophagosome
formation. The Atg9 system (Atg-2-Atg9-Atg18) assists in membrane delivery of the expanding
autophagosome. The Ptdlns3K complex (Vps15-Vps34-Vps30-Atg14) is involved in vesicle
nucleation. The Atg12 (Atg-7-Atg10-Atg12-Atg16) and Atg8 (Atg3-Atg3-Atg7-Atg8) systems
are involved in autophagosome expansion. Following completion of the autophagosome, the
vesicle will dock and fuse with autolysosomes and become degraded (69-72).
1.2.2

Necroptosis

Necroptosis is defined as a regulated process of necrosis and was initially described as a
process that shares both apoptotic and necrotic features alongside inhibition of classical apoptotic
pathways (73). Morphologically, cells undergoing necroptosis largely mimic necrosis,
characterized by cellular swelling, chromatin condensation followed by nuclear decondensation,
rupturing of the plasma membrane, and release of intracellular contents (74-77).
Necroptosis is initiated by signaling from ligation of death molecules to death receptors
(FAS/FASL, TNF1/TNF2, TRAILR1/TRALR2). Complex I (TRADD-TRAF2/TRAF5-RIP1cIAPs-NEMO-CLYD) is a signaling complex and cellular checkpoint that is formed thereafter
and can either result in nuclear factor-κB (NF-κB) pathway activation and cell survival, or in
formation of the death-inducing signaling complex (DISC, or complex II) that promotes cell
death (78,79). When caspase 8 is uninhibited, the cell executes apoptotic cell death (80). When
caspase 8 is inhibited, however, cIAP1 ubiquinates RIPK1, causing RIPK1 and RIPK3 to form
complex II (i.e. necrosome) (81). Complex II leads to the phosphorylation of MLKL, a key step
in the execution of necroptosis (82,83). The execution of necroptosis is reported to occur in
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multiple ways including events like production of ROS, overactivation of the DNA repair and
transcription regulatory PARP1, release of the apoptosis-inducing factor (AIF) from the
mitochondria to the nucleus to initiate DNA fragmentation, promotion of pore formation, and
PGAM5-induced mitochondrial fragmentation (84-88).
1.2.3

Apoptosis

Apoptosis is considered the most understood PCD pathway and is evolutionarily
conserved in metazoans. Apoptosis relies on activation of caspases and proteins that degrade
organelles in preparation for controlled cell death (89). Morphological hallmarks of apoptosis are
membrane blebbing, cell shrinkage, DNA condensation, DNA fragmentation, and formation of
non-lytic apoptotic bodies. This death process is notably non-inflammatory and thus does not
damage or stress surrounding cells (90). Intrinsic and extrinsic stimuli can induce apoptosis, and
the distinct pathways responsible for these are thus termed the intrinsic pathway and the extrinsic
pathway (91,92). Though these pathways differ in induction, they share the same execution
phase.
The intrinsic pathway is mediated by the family of Bcl proteins including the proapoptotic Bax proteins and the anti-apoptotic Bcl-2 proteins (93). The pro-apoptotic poreforming proteins BAX and BAK are mitochondrial membrane proteins in the outer membrane
and cause outer membrane permeabilization (MOMP) when activated by pro-apoptotic BH3only proteins (BID, PUMA, BAD, BIK, BIM, BMF, Hrk, and Noxa) (94,95). MOMP releases
apoptosis-inducing proteins from the inner mitochondrial membrane (91). These proteins, such
as cytochrome c, activate caspases and inhibit caspase-inhibitor proteins. Of particular
importance is activation of caspase 9 and the executionary caspases 3, 6, and 7 (96,97). Because
apoptosis results in death of cells, there are multiple anti-apoptotic proteins that keep the
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pathway tightly regulated. Some of these proteins include BCL-2 proteins (BCL-2, BCL-XL,
BCL-W, BFL1, and MCL1) which inhibit the release of cytochrome c (94). These proteins bind
to BIM and BID, preventing BAX and BAK activation.
The extrinsic pathway involves death receptors that interact with specific adaptor
proteins. These death receptors are characterized by a conserved domain termed the “death
domain” and includes members of the tumor necrosis factor (TNF) family in addition to other
ligands and receptors such as Apo3L/DR3, Apo2L/DR4, FasL/FasR, and TNFα/TNFR1 (98). In
general, recruitment of FADD, TRADD, and RIP allows for association with procaspase-8,
forming a complex called the DISC (98,99). At this point, apoptosis is executed with caspase-8
and caspase-8 cleaving the executionary caspase-3 (100). Some inhibitors for this pathway also
exist, including c-FLIP and Toso (101,102).
1.2.4

Ferroptosis

First proposed in 2012, ferroptosis is a non-apoptotic form of PCD directly associated
with iron-dependence and abundance of lipid ROS (103). Notably, ferroptosis does not share
morphological hallmarks of necrosis (cellular swelling and rupture of the plasma membrane) or
apoptosis (cellular shrinkage, chromatin condensation, or apoptotic body formation) (103,104).
Instead, cells undergoing ferroptosis exhibit mitochondrial shrinkage, reduction or dissolution of
mitochondrial cristae, and increased membrane density (103,105). In mammalian cells,
ferroptosis occurs when glutathione (GSH) is depleted, resulting in decreased glutathione
peroxidase 4 (GPX4) activity and accumulation of lipid peroxides (105). As a consequence, irondependent oxidation of lipids occurs and excessive ROS is produced (105). Multiple molecular
systems of ferroptosis have been implicated (106). For example, the Xc- system (SLC7A11SLC3A2), an amino acid anti-transporter localized to plasma membrane, has antioxidative roles
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(107). Cysteine, an amino acid regulated by this system, plays a role in GSH synthesis.
Therefore, when system Xc- is inhibited, GSH cannot reduce ROS via glutathione peroxidases,
leading to accumulation of lipid ROS. Additionally, any suppression of GPX4, such as with the
inducer of ferroptosis RSL3, results in accumulation of lipid ROS. Excessive ferrous iron can
also lead to initiation of ferroptosis due to lipid-peroxidation and production of ROS (108).
There have been connections with other cellular processes as well such as autophagy, the
mevalonate pathway, and sulphur-transfer pathways (107-109).
1.2.5

Paraptosis

Paraptosis, first described in 2000, is another non-apoptotic pathway (112). Paraptosis
lacks caspase involvement, mitochondrial and endoplasmic reticulum (ER) swelling, and
significant cytoplasmic vacuolization (110). Unlike apoptosis, paraptotic cells do not exhibit
nuclear fragmentation or membrane blebbing (111). The molecular mechanism of paraptosis is
unknown. Inhibition of gene expression with actinomycin D and cycloheximide prevent
paraptosis (110).
1.2.6

Oxeiptosis

Oxeiptosis is an RCD program triggered exclusively by elevated ROS. Accumulation of
ROS can cause oxidative damage to the intracellular ROS sensor KEAP1, leading to
conformational change of the protein and impairing its ability to bind to the transcription factor
NRF2. NRF2 then translocates to the nucleus to express cytoprotective genes to protect the cell
anti-oxidatively (112,113). Apparently, when ROS levels are excessive, oxeiptosis is triggered
and KEAP1 is displaced from the mitochondria, disassociating from the protein PGAM5.
PGAM5 internalizes into the mitochondrion from the outer membrane and dephosphorylates
AIFM1 to trigger caspase-independent cell death (114,115). Morphological details of cells
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undergoing oxeiptosis are largely unexplored. It was identified as a unique cell death process
given it is caspase-independent, non-inflammatory, RIPK3-independent, ROS-induced, and
KEAP1-PGAM5-AIFM1 dependent (115).
1.2.7

Pyroptosis

Pyroptosis is a lytic inflammatory pathway (the inflammasome pathway) that occurs in
immune cells in the innate immune system and is triggered upon infection by intracellular
pathogens. It has been associated with regulated lysis of cells infected by viruses, bacteria,
fungus, and protozoans (118). Although initially thought to be a form of apoptosis given its
shared caspase involvement, DNA fragmentation, and nuclear condensation, pyroptosis is now
recognized as having a unique morphologic profile centered on its pro-inflammatory outcome
following cellular swelling and plasma membrane rupture (116-119). The process is induced by
caspase-1, caspase-4, caspase-5, and caspase-11 (120). Assembly of the inflammasome complex
occurs in response to pathogen-associated molecular patterns (PAMPs) and exogenous pathogens
and endogenous damage-associated molecular patterns (DAMPs) and endogenous damage
(121,122). Sensors for assembly induction include NLRP1, NLRp3, NLRC4, AIM2, and pyrin.
Once the sensors are activated by PAMPs and DAMPs, the inflammasome complex (CARDprocaspase-1-NLRP3-PYD) forms, caspase-1 become active and cleaves the executioner
gasdermin D (GSDMD), ultimately leading to cell membrane perforation (120,123,124).
1.2.8

Parthanatos

Parthanatos, a pathway identified only a decade ago, is based on genomic stress and the
protein poly(ADP-ribose) polymerase-1 (PARP-1), a nuclear enzyme that repairs DNA and is
involved in transcription (125). Parthanatos shares similar morphological features with apoptosis
and necrosis (nuclear disruption, chromatin condensation, cell lysis, and DNA fragmentation)
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(126). PARP-1 associates with poly(ADP-ribose) (PAR), a molecule that binds to target proteins
to regulate processes such as DNA repair and transcription (126). When there is DNA damage,
PARP-1 becomes active, leading to ADP-ribosylation of transcription factors, single-strange
break repair factors, and base-excision repair factors (127). When excess genotoxic stress is
apparent in the cell, PARP-1 becomes overexpressed and produces excessive PAR (125). The
execution of cell death is thought to be caused by depletion of NAD+ and ATP, as overactivation
of PARP-1 has resulted in fatal energy loss (128). The overactivation of PARP-1 has also been
linked to release of AIF from the mitochondria and its associated effects on nuclear apoptosis, as
mentioned previously in necroptotic pathways (87).
1.3

Cell Death in Trypanosomatids
Programmed cell death in trypanosomatids was first observed in 1995 in T. cruzi during

in vitro differentiation and was characterized by cytoplasmic changes, nuclear changes, and
DNA fragmentation (129). Since then, various features of PCD have been observed in numerous
trypanosomatid species. Recently, Menna-Barreto reviewed the current evidence of cell death
pathways in pathogenic trypanosomatids, collectively reiterating that trypanosomatids exhibit
apoptotic-like phenotypes, undergo autophagy, and exhibit necrosis and emphasizing the
following questions: (1) what is the biological relevance of PCD in unicellular protozoans? and
(2) what molecular machinery is involved in PCD pathways (130)? There has been evidence that
Trypanosoma spp. and Leishmania spp. exhibit numerous hallmarks of apoptosis and oncosis.
These characteristics include DNA fragmentation (129), phosphatidylserine externalization
(131), loss of mitochondrial potential (ΔΨm) (132), cytochrome c release (133), chromatin
condensation (134) , and plasma membrane disruption (135). Additionally, evidence supports the
biochemical presence of autophagy as characterized by Atg participation, formation of
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phagophores and autophagosomes, and the activity of lysosomes (136). Furthermore, many stress
conditions well understood in other models have also prompted cell death responses. These
include drug treatment, thermal stress, oxidative stress, starvation, and hypoxia (129,131,137141). Trypanosomatids also exhibit apoptosis-like features during parasite differentiation (129).
Little is known about the responsible molecular mechanisms responsible for PCD in
trypanosomatids as deep genome analysis has not produced homologs of important apoptosisinvolved molecules. Various potential players have been investigated. In 1998, Welburn and
Murphy identified the trypanosome homologs for prohibitin, a transcriptional modulator, and
activated protein kinase C (RACK), a regulator of cell cycle progression (142). They emphasized
the upregulation of these genes in T. brucei undergoing concanavalin A-induced cell death. It has
been proposed that this correlation between RACK, prohibitin, and the apoptotic phenotype is
evidence for the convergence between mammalian and parasite pathways (142). Zangger et al.
demonstrated that Leismania parasites exhibit DNA fragmentation, a late-stage event of
apoptosis, and correlated this with presence of internucleosomal nuclease activity by two
specific, unidentified nucleases (143). They additionally reported that DNA fragmentation was
independent of typical cofactors of mammalian nucleases (Ca2+ or Mg2+) and caspase activity. It
is known that trypanosomatids lack caspase-activity. Metacaspases, cysteine proteases that are
analogous to caspases, induce PCD in plants and fungi (144). Although trypanosomatids
metacaspases share the same folding pattern to mammalian caspases, there is no evidence to date
that these proteins are involved in PCD (132). In accordance with this, there are multiple studies
demonstrating that the parasites die in a metacaspase-independent manner with association with
other proteins such as endonuclease G (145), inosine 5’ monophosphate dehydrogenase (146),
and cysteine proteases CPA and CPB (143).
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Similar to mammalian models, it is apparent the trypanosomatids mitochondrion plays an
important role in cell death (147). Conditions such as H2O2, starvation, heat stress, ER stress, and
antiparasitic drugs have been shown to induce cell death across various trypanosomatids and
additionally results in loss in ΔΨm (132,134,148,149). This is further supported by evidence of
induction of apoptosis-like death with Ca2+ imbalance and chemical inducers of ROS production
(148). Smirlis et al. reviewed two present suggested pathways that describe the interplay of Ca2+,
ROS, and ΔΨm (150). The first pathway involves cytosolic Ca2+ elevation, which enters the
mitochondria and disrupts the ΔΨm and ROS production. Excessive mitochondrial Ca2+
accumulation and cell death ensue in T. cruzi following treatment of parasites to fresh human
serum. The second pathway involves induction of ROS production which triggers lipid
peroxidation. The peroxidation of lipids thereafter results in membrane fluidity and functionality
of Ca2+ channels, leading to excess accumulation of Ca2+ and loss of ΔΨm (151). This pathway
was seen in L. donovani parasites following treatment with complex II inhibitor thenyltrifluoroacetone and H2O2 (151). Downstream effects that follow ΔΨm disruption of either pathway result
in the execution of apoptosis include protease and nuclease activation.
Menna-Barreto concluded their review by reiterating the fact that there are currently no
biochemical or molecular tools catered to protozoa for investigating programmed cell death.
There are no streamlined or commercially-available tools exist to track these apoptotic-like or
autophagic events. The magnitude of the mystery that is PCD in trypanosomatids continues to
warrant investigation given the established clinical burden of these parasites.

16
2
2.1

RATIONALE

Hypothesis
Given the evolutionary and phylogenetic relationship of Crithidia fasciculata with human

pathogens of Trypanosoma and Leishmania, I hypothesize that C. fasciculata will exhibit
apoptosis-like and oncosis-like morphological characteristics in response to thermal stress,
oxidative stress, rotenone, and nutrient deprivation. I also hypothesize that these parasites will
largely lack homologs for key molecules involved in established cell death pathways as seen in
mammalian systems.
2.2

Specific Aims
2.2.1

Identify trypanosomatid homologs of potential proteins involved in cell death

As apoptosis and autophagy are well characterized systems, the search for key molecules
involved in these pathways has previously been conducted in trypanosomatids. Limited data
have been published on protein partners involved in more novel cell death pathways. This project
aims to perform a comprehensive analysis of trypanosomatids genomes for all major molecules
involved in eight different regulated cell death pathways. To achieve this, I:
•

Performed BLASTp analysis of trypanosomatid genomes for homologs of key molecules
involved in various PCD pathways

•

Reviewed the literature to understanding roles of homologs in trypanosomatids, and

•

Connected existing key molecules and physiological profiles to determine possible
existing PCD’s in C. fasciculata
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2.2.2

Determine methods to induce and measure cell death in C. fasciculata

Thus far, there have been little data published on methods to induce cell death in C.
fasciculata. Although certain stressors and their effects have been explored in pathogenic
trypanosomatids, differences in treatment conditions have been observed between these species.
For example, apoptosis-like death in T. cruzi in response to H2O2 occurs in the micromolar range
however in L. donovani, optimal treatment is in the millimolar range (132,152). Given there
seem to be specific pathways in higher eukaryotes to combat specific triggers of cell death, it is
critical to investigate how cells react to individual stressors. To investigate patterns of cell death,
I aim to:
•

Optimize the staining conditions of Hoechst 33342, propidium iodide, annexin-V, and
monodansylcadaverine

•

Determine conditions to induce cell death (but not necrosis)

•

Determine the ranges of temperatures at which C. fasciculata undergo necrosis

•

Determine concentrations at which H2O2and rotenone are cytotoxic

•

Determine the conditions at which C. fasciculata form autophagic vacuoles

2.2.3

Characterize cellular morphology during cell death

Each cell death pathway is characterized by cellular morphological profiles. Although
some features may be shared between RCD pathways, analyzing a morphological profile during
cell death can be useful in identifying the pathway at hand. Rather than functionally investigate
molecular partners responsible for certain cell death pathways, this study aims to determine the
various morphological characteristics that C. fasciculata display when undergoing cell death.
Characterization of morphological profiles involved:
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•

Capturing and identifying morphological patterns when cells were stressed

•

Describing a morphological “sequence” of cell death

•

Identifying instances of mammalian hallmarks such as cell shrinkage and swelling

•

Comparing witnessed morphological profiles to those of existing regulated cell death
pathways

2.2.4

Characterize nuclear changes during cell death

Many PCD pathways involve damage to DNA and understanding processes that occur in
the nucleus can help in characterizing differences in cell death pathways. It has previously been
shown that some trypanosomatids display different nuclear changes from mammals, despite
attempts at mimicking specific stressors applied in mammalian systems (148). Furthermore, little
is known about the role of the kinetoplast during cell death processes. Thus far, no studies
address nuclear morphology of C. fasciculata in response to stress. In order to characterize
nuclear changes, the following steps were taken:
•

Determine the optimal method of staining and analyzing DNA bodies

•

Identify patterns of nuclear changes during cellular stress

•

Identify instances of mammalian hallmarks such as DNA fragmentation and chromatin
condensation

•

Compare nuclear morphological profiles to those of existing regulated cell death
pathways
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3
3.1

METHODS

Reagents
Brain heart infusion (BHI) media was obtained from Becton Dickinson. Fetal bovine

serum (FBS) was obtained from Atlanta Biologicals. Penicillin-streptomycin was obtained from
CellGro. Hemin was obtained from Alfa Aesar. GeneJet Genomic DNA Purification Kit, SYBR
Safe DNA Stain, and 1Kb Plus DNA ladder were obtained from Thermo Scientific. Agarose and
phenol/chloroform/isoamyl alcohol, chloroform, and absolute ethanol was obtained from Fisher
Bioreagents. Poly-l-lysine, propidium iodide, monodansylcadaverine, and rotenone were
obtained from Sigma Aldrich. Hoechst 33342 was obtained from Invitrogen. The Annexin V
Fluorescence Microscopy kit was obtained from BD Biosciences. Three percent (3%) hydrogen
peroxide was obtained from Walmart. Sixteen percent (16%) paraformaldehyde was obtained
from Electron Microscopy Sciences. Isoamyl alcohol was obtained from Mallinckrodt.
3.2

Parasite culture
Wild type Crithidia fasciculata (Cf-Cl strain generously provided by Dan Ray, UCLA)

were typically grown at room temperature and shielded from light in non-treated tissue culture
flasks. Cells were maintained in BHI media supplemented with FBS, hemin (2.5 µg mL-1), and
penicillin-streptomycin (100 IU / 100 µg mL-1). Regular cell maintenance typically involved
passage of 500 µL of cells into 5 mL complete media every 5-7 days. When preparing for
morphology experiments, cells were passaged to a new cell culture flask and incubated at room
temperature (RT) on an orbital tabletop shaker under a sheet of aluminum foil (58). Experiments
were conducted on cells in mid-log phase, approximately 108 cells mL-1. For cultures grown in
static conditions, this was typically achieved in 24-48 hours. For rotating cultures, this was
typically achieved in 24 hours. Cell density was determined by counting on a hemocytometer.
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3.3

Bioinformatics analysis
Literature review was conducted to identify relevant molecules involved in apoptosis,

necroptosis, ferroptosis, oxeiptosis, paraptosis, pyroptosis, autophagy, and parthanatos.
Accension numbers of each protein and the respective amino acid sequences were obtained from
the UniProt database (153). For autophagy, protein from Saccharomyces cerevisiae were used as
query sequences for BLASTp with the exception of ATG25 from Pichia angusta. For all other
pathways, Homo sapiens proteins were used. FASTA-formatted, amino acid sequences were
used for BLASTP against TriTrypDB (v.56) (144) with target organisms Crithidia fasciculata
strain Cf-Cl, Leishmania major strain Friedlin, Trypanosoma cruzi strain CL Brener Esmeraldolike, and Trypanosoma brucei strain TREU927 (154,155). The maximal e-value was set to 10,
and the maximum descriptions/alignments was set to 50. The low complexity filter was enabled.
Homologs were determined by assessing significance of e-values (less than e-4) and score
(greater than 40). When it was apparent that multiple homologs may exist, the trypanosomatid
sequences were reverse-searched by submission to NCBI’s BLASTp function against H. sapiens
(or the respective yeast for autophagy). In order to qualify as a homolog, the query protein
needed to be the top hit.
3.4

Stress treatments
Prior to stress treatments, cells were passaged at least twice to ensure a healthy, active

culture. Twenty four hours (rotating cultures) or 48 hours (static cultures) after passage, cells
density was determined to ensure mid-log phase. Inside the biosafety cabinet, cells were
generally washed once with room temperature, sterile PBS and resuspended in complete BHI
media at the original volume prior to treatment. All washing steps involved centrifugation at
8,000 RCF for 5 minutes at room temperature.
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3.4.1

Thermal stress

Depending on the volume of the sample of cells, heat stress was applied via three
different methods: (1) tabletop heat block, (2) thermal cycler, (3) or water bath. Cells were
suspended in complete BHI media at the appropriate volume and exposed to constant heat at
specified temperatures. Following treatment, cells were washed once with PBS before staining.
For heat shock treatments, similar steps were taken with the exception of shortening the
exposure time to 15 minutes and allowing cells to rest at RT, without shaking, and shielded from
light for 4 hours.
3.4.2

Starvation

Starvation involved washing cells with sterile PBS three times to remove residual media.
Cells were then resuspended in either BHI media depleted of FBS or sterile PBS. Flasks were
then left at RT, without shaking, and shielded from light for the set period of time.
3.4.3

Oxidative stress

Cells were centrifuged and resuspended in complete BHI with hydrogen peroxide at 25,
50, 100, 250, and 500 mM. Because stock hydrogen peroxide was 0.88 M (3% in water), a large
volume of peroxide had to be added to attain higher doses. Thus, of the total sample volume in
some cases, 56% of the total volume was water added with the peroxide. To account for possible
cell volume stress, the percent of water for each sample was controlled by adding water to the
same final concentration in the control and all treatments. Following treatment, cells were
washed twice with PBS to remove residual H2O2. This prevented continued exposure to drug
when moving to staining and slide preparation.
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3.4.4

Rotenone

Rotenone was made by dissolving in 100% ethanol to a 2.5 mM (1 mg mL-1) solution.
Cells in fresh complete BHI media were treated with the appropriate concentrations of rotenone
(2 µM and 10 µM). As ethanol can be toxic towards the parasites, rotenone treatments involved
adding low volumes of solubilized drug (0.08% to 0.4% of total volume). Treatments were
performed at RT, static, shielded from light, for 24 hours. Following treatments, cells were
washed twice with PBS to remove residual drug.
3.5

Staining and Microscopy
3.5.1

Slide preparation

Coverslips were coated with poly-l-lysine (diluted 1:10 from stock in PBS) for 5 minutes
followed by 15 minutes of air drying. Following treatment and the appropriate wash steps, cells
were stained with fluorescent dyes, washed with PBS, and aliquoted onto a glass microscope
slide. PLL coverslips were then placed onto the cells and allowed to adhere for 10 minutes. The
perimeter of coverslips was then sealed with clear nail polish.
3.5.2

Staining parameters

Prior to labeling with annexin-V, cells were washed once with PBS containing calcium
followed by an additional wash with a 1:1 ratio of annexin-V binding buffer. Cells were then
resuspended in annexin-V binding buffer containing annexin-V (diluted 1:10 from manufacturer)
and propidium iodide at 1.5 µM (1 µg mL-1) and incubated 15 minutes in the dark.
Cells were stained with propidium iodide at a final concentration of 1.5 µM. Stock PI was
prepared by dissolving in PBS at either 748 µM (0.5 mg mL-1) or 1.5 mM (1 mg mL-1).
Monodansylcadaverine (MDC) was dissolved in DMSO, and aliquots were stored at -20
ºC. MDC staining was at 50 µM. Due to cytotoxic properties of DMSO, MDC was dissolved at
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2.98 mM (1 mg mL-1) to minimize the amount of DMSO added per sample. Cells were stained
for 30 minutes in the dark.
Hoechst 33342 (stock of 22 mM, 10 mg mL-1) staining was conducted at 4.42 mM (2 µg
mL-1) for 30 minutes in the dark. Generally, stained cells were not washed prior to analysis.
3.5.3

Data collection

Phase contrast and fluorescence images were captured under non-saturating conditions
using Axio Imager.A1 fluorescence microscope (Zeiss) with an AI-6MPCMPS digital camera
driven by AI View software (Aiken Instruments). Filter sets for the microscope included:
HQ545/30 + HQ610/75M (Red, Chroma), HQ480/40X + HQ535/50 (Green, Chroma), and G365
+ BP445/50 (Blue, Zeiss). Slides were first visualized on phase contrast and frames containing
cells were haphazardly selected for data collection. In general, if a frame had cells that were in
the same focal plane and not overlapping with other cells, the field of view was selected for
analysis. Following capture of phase contrast images, fluorescence images were taken. In cases
where Hoechst 33342 was used, the Hoechst 33342 images were taken first due to the dye’s
tendency to bleach. Care was taken to image fields not previously exposed to excitation light to
minimize bleaching. For each slide, at least 300 cells were captured and analyzed. Clusters or
clumps of cells, cells near the perimeter of the cover slip, or cells in air pockets were excluded
from analysis. Post-capture modifications (e.g., sharpness, contrast, and brightness) to improve
visibility were applied equally to all photos via PowerPoint (Microsoft). All experiments were
performed in triplicate.
3.6

Assessing morphology
To assess the effects of stress on morphology of the nectomonad, swimming cells, flasks

were cultured on a shaker as described above. They were then stressed at necrosis-inducing (46-
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50 °C) and non-necrosis-inducing (38-44 °C) temperatures for 1 hour in a heat block. Cells were
then fixed with 4% paraformaldehyde for 15 minutes, stained with propidium iodide, and
analyzed. Slides were first viewed under phase contrast and scanned for reoccurring cell
phenotypes (e.g., rounding, swelling, shrinkage) across all treatment groups followed by
capturing of fluorescence images. Post-capture, phase contrast images were first grouped
categorically via cell phenotype followed by assessment of patterns in propidium iodide
staining.
To assess changes in nuclear morphology, cells were either stressed with rotenone (2
µM) or heat stressed (44 ºC) as described above. Cells were then double-stained with Hoechst
33342 and propidium iodide. Given the difficulty to discern differences in shapes of the nucleus
via Hoechst staining, changes in nuclear morphology were gauged by chromatin condensation.
To this end, it was important to begin experiments with control groups and maintain the same
exposure and gain for all filter sets of the following treatment groups. To differentiate between
the nucleus and kinetoplast, which are always present when staining DNA, the nucleus was
identified as the larger, dimmer organelle, and the kinetoplast was identified as the relatively
smaller, brighter organelle.
3.7

DNA fragmentation assay
To obtain genomic DNA for fragmentation analysis, each sample of parasites was grown

in a 75 cm2, non-treated cell culture flasks with a total culture volume of 15 mL. Once the
appropriate density and mid-log phase was reached, cells were then stressed with the treatment
of interest. Following stress, cells were pelleted down at 1550 g at RT for 10 minutes, and the
supernatant was removed. Pellets were stored at -80 °C until ready for nucleic acid extraction.
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Genomic DNA extraction begun with thawing frozen cell pellets to RT and washing once
with RT PBS. Cells were resuspended in 1000 µL GeneJET Genomic DNA purification lysis
solution with 1/10 volume proteinase K solution and incubated at 56 °C for 4 hours. The solution
was intermittently vortexed to promote lysis. Cell debris was pelleted down at 18,000 × g for 15
minutes at 4 °C. After addition of 1/20 volume of RNase A solution, lysates (supernatants) were
incubated at 37 °C for an additional hour. One volume of phenol:chloroform:isoamyl alcohol
(25:24:1) was added to the sample and vortexed at max setting for 30 seconds. Samples were
then centrifuged at 16,000 × g for 5 minutes at RT. The upper aqueous layer containing DNA
was transferred and mixed with an equal volume of RT chloroform:isoamyl alcohol (24:1) by
vortex for 30 seconds. The centrifugation step was repeated and again the upper aqueous layer
was transferred to a new tube. DNA was precipitated by adding 1/10 volume of 3M NH4OAc
and 2.5 volumes of ice cold 100% ethanol. Samples were incubated at -20 °C overnight. Samples
were then centrifuged for 15 minutes at maximum speed at 4 °C, and the pellet was washed once
with ice cold 80% absolute ethanol. The pellet was air dried for 5 minutes, resuspended in
elution buffer, and quantified via spectrophotometer (NanoDrop).
A 1% agarose gel was created by boiling 0.4 g of agarose in 40 mL TAE buffer. Before
casting the gel, 4 µL of SYBR safe DNA stain (0.01%) was added and well mixed. After the gel
solidified, 10 µg of DNA diluted with 1X loading dye (made in house) was loaded in the gel and
electrophoresed at 135 volts and 125 milliamps. DNA was visualized with a Safe Imager Blue
Light Transilluminator (Invitrogen), and photos were captured with a mobile phone camera.
Post-modification of gel images (invert, desaturate, contrasts) was applied non-favorably to all
gels via Microsoft PowerPoint. The experiment, including all treatment groups and separate
gDNA extractions, were repeated once.
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3.8

Statistical analysis
Statistics were performed via Prism 9.2 (GraphPad). Data was analyzed by one-way

analysis of variance (ANOVA), and differences between control and experimental groups were
analyzed by t-test. p values less than 0.05 were considered statistically significant.
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4
4.1

RESULTS

Identification of homologs associated with cell death processes
To determine if relevant genes involved in various cell death processes existed in

trypanosomatids genomes, amino acid sequences of proteins from reference species were
submitted to BLASTp analysis against reference strains of C. fasciculata, L. major, T. brucei,
and T. cruzi (Tables 1-8). Homology was determined by TriTrypDB scoring and e-value and
further supported, when applicable, by identification of conserved superfamily or family
domains. Homology required single, confident results that matched the query. In instances where
multiple hits to homologous hypothetical proteins, amino acid sequences in question were
submitted to reverse-BLASTp search against the reference species to confirm match. In order to
better understand the potential presence of each PCD pathway in trypanosome biology, each
protein was generally categorized by function, members, or pathways depending on current
understanding of each regulated cell death pathway (Figure 1).
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Figure 1 Trypanosomatids lack key molecules involved in necroptosis, apoptosis,
paraptosis, pyroptosis, and oxeiptosis. They however have conserved genes involved in
ferroptosis, autophagy, and parthanatos. Molecules involved in PCD pathways were categorized
by function, members, or pathways. Presence of homologs identified by BLASTp of C.
fasciculata, L. major, T. brucei, and T. cruzi genomes is indicated by highlighting. Red text
indicates homology in 1-3 parasites. Black text indicates homology in all 4 species. Grey text
indicates homology was not identified in typanosomatid genome..

Aside from ATG21, all 4 species share significant orthology for proteins involved in
autophagic induction and signaling (ATG1, ATG20, ATG24, TOR1, TOR2), nucleation (VPS15,
VPS34), and expansion and endpoint (ATG3, ATG4, ATG7, ATG8, ATG9, ATG18). However,
nearly half of the ATG’s identified in the representative species S. cerevisiae are absent (Table
1). A potential ATG21 homolog is evident in the Trypanosoma spp. genome but is absent from
both C. fasciculata and L. major. Proteins involved in autophagic packaging were not identified
any of the trypanosomatid genomes.
Trypanosomatids appear to lack all key molecules involved in necroptosis, including
proteins involved in death signaling and receptors, complex I and complex II formation, and
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execution (Table 2). Additionally, ZFP36, the gene encoding for mRNA decay activator protein,
a stabilizer of RIP1 and ripoptosome assembly, is conserved in all species except T. cruzi. Of
note, a single hit for TRAF2 was identified for C. fasciculata (CFAC1_220030700) due to
identification of the TRAF superfamily domain. Similarly, a hit for TRAF5 was identified each
in L. major (LmjF.07.0370) and T. brucei (Tb927.11.4660).
As apoptosis is the most well defined cell death pathway, extensive BLASTp involved
search of numerous proteins in the trypanosome genome (Table 3). In agreement with present
data, trypanosomatids lack almost all proteins involved in extrinsic and intrinsic apoptosis aside
from cytochrome c, 14-3-3 proteins, endonuclease G, prohibitin, and TMBIM5 (130). TMBIM5
is involved in organization of the mitochondrial architecture and release of cytochrome c, an
important molecule in initiating apoptosis (156). Prohibitin is known to play a role in
mitochondrial-associated apoptosis (142). Endonuclease G is responsible for fragmenting DNA
during apoptosis (143). Trypanosomatids lack procaspases but have conserved genes for
metacaspases-1, -2, -3, -4, and -5, none of which have been functionally linked to regulated cell
death in protozoans (130).
Although only a few key molecules in parthanatos have been identified, three of these
(PARP1, PARG, and MIF) are selectively conserved in trypanosomatids (Table 4). Leishmania
major lacks homology for PARP1 and PARG. Trypanosoma spp. do not possess proteins
homologous for MIF. AIF was not identified for any of the species.
Trypansomatids possess putative homologs for multiple key molecules involved in
ferroptosis including GPX4, FSP1, DHODH, ACSL4, SLC7A11, GSH, and GBLB (Table 5).
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As aforementioned, the molecular machinery involved in paraptosis is largely unexplored
though it is noted that trypanosomatids do not possess homologs for caspases-1, -4, or -5 or
GDSMD (Table 6).
As trypanosomatids do not possess immune systems, it could have been expected that
they do not have conserved genes involved in pyroptosis aside from NLRP3, one of the known
receptors responsible for initiating inflammasome assembly (Table 7).
Although trypanosomatids possess orthologs for PGAM5, they lack orthologs for
KEAP1, both of which encode for the two key molecules involved in oxeiptosis (Table 8).
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Table 1. Genes involved in autophagy and identified trypanosomatid homologs
Gene Identification numbers of relevant Saccharomyces cerevisiae molecules were identified by
UniProt and homologs in trypanosomatids were determined via BLASTp search. ATG25 was
represented by Pichia angusta as this gene is not present in S. cerevisiae. Orthologs between the
four trypanosomatid species were identified by TriTrypDB version 54.
GeneID
VPS34

ATG1

Organism UniProt ID
S. cerevisiae p22543

S. cerevisiae

p53104

Organism
C. fasciculata

TriTrypDB ID
CFAC1_250050500

Score
223

E-value
3.00E-60

L. major

LmjF.24.2010

221

1.00E-59

T. brucei

Tb427.08.6210

271

7.00E-76

T. cruzi

TcCLB.511065.50

239

3.00E-70

C. fasciculata

CFAC1_200027900

122

8.00E-28

L. major

LmjF.29.2020

120

4.00E-27

T. brucei

Tb927.3.4560

116

6.00E-26

T. cruzi

TcCLB.504089.54

117

5.00E-26

ATG13

S. cerevisiae

Q06628

None identified

ATG6

S. cerevisiae

Q02948

None identified

ATG5

S. cerevisiae

Q12380

None identified

ATG20

S. cerevisiae

Q07528

C. fasciculata

CFAC1_300073200

47.4

3.00E-05

L. major

LmjF.35.2420

50.4

3.00E-06

T. brucei

Tb927.9.13380

50.8

2.00E-06

T. cruzi

TcCLB.510749.30

58.9

6.00E-09

ATG17

S. cerevisiae

Q06410

None identified

VPS53

S. cerevisiae

P47061

C. fasciculata

CFAC1_170016900

214

1.00E-58

L. major

LmjF.19.0810

216

1.00E-58

T. brucei

Tb927.10.15540

184

3.00E-48

C. fasciculata

CFAC1_300073200

47.4

5.00E-05

L. major

LmjF.35.2420

49.3

1.00E-05

T. brucei

Tb927.9.13380

77.8

9.00E-15

T. cruzi

TcCLB.510749.30

74.7

1.00E-13

T. cruzi
ATG24

ATG11

S. cerevisiae

S. cerevisiae

P47057

Q12527

None identified
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ATG19

S. cerevisiae

P35193

None identified

ATG 3

S. cerevisiae

P40344

C. fasciculata

CFAC1_280011000

99.8

2.00E-23

L. major

LmjF.33.0295

108

1.00E-26

T. brucei

Tb927.2.1890

67

7.00E-12

T. cruzi

TcCLB.510257.90

103

2.00E-24

ATG14

S. cerevisiae

P38270

None identified

ATG4

S. cerevisiae

P53867

C. fasciculata

CFAC1_300048700

90.9

2.00E-19

L. major

LmjF.32.3890

96.7

2.00E-21

T. brucei

Tb927.11.16290

98.2

3.00E-22

T. cruzi

TcCLB.511527.50

118

3.00E-29

ATG5

S. cerevisiae

Q12380

None identified

ATG7

S. cerevisiae

P38862

C. fasciculata

CFAC1_080005700

310

2.00E-94

L. major

LmjF.07.0010

297

8.00E-90

T. brucei

Tb927.10.11180

328

4.00E-101

T. cruzi

TcCLB.507711.150

343

7.00E-107

C. fasciculata

CFAC1_210026000

129

1.00E-38

L. major

LmjF.19.1630

130

4.00E-39

T. brucei

Tb927.7.5900

132

1.00E-39

T. cruzi

TcCLB.510533.180

92

5.00E-23

T. brucei

Tb927.3.4150

55.52

5.00E-09

T. cruzi

TcCLB.509669.100

53

2.00E-07

ATG8

S. cerevisiae

P38182

ATG10

S. cerevisiae

Q07879

None identified

ATG12

S. cerevisiae

P38316

None identified

ATG16

S. cerevisiae

Q03818

None identified

ATG21

S. cerevisiae

Q02887

C. fasciculata
L. major

ATG27

S. cerevisiae

P46989

None identified

ATG2

S. cerevisiae

P53855

None identified

ATG23

S. cerevisiae

Q06671

None identified
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ATG22

S. cerevisiae

P25568

None identified

ATG25

P. angusta

Q6JUT9

None identified

ATG26

S. cerevisiae

Q06321

C. fasciculata

CFAC1_110012800

46

2.00E-04

T. cruzi

TcCLB.508089.20

45.1

4.00E-04

C. fasciculata

CFAC1_230049000

49.3

2.00E-05

L. major

LmjF.27.0390

57.8

5.00E-08

T. brucei

Tb927.11.990

44.7

1.00E-04

T. cruzi

TcCLB.506925.450

50.1

9.00E-06

C. fasciculata

CFAC1_200022900

53.5

3.00E-07

L. major

LmjF.29.1575

59.7

4.00E-09

T. brucei

Tb927.3.4150

97.8

1.00E-21

T. cruzi

TcCLB.509669.100

90.5

4.00E-19

L. major
T. brucei

ATG9

ATG18

S. cerevisiae

S. cerevisiae

Q12142

P43601

ATG15

S. cerevisiae

P25641

None identified

ATG29

S. cerevisiae

Q12092

None identified

ATG31

S. cerevisiae

Q12421

None identified

VPS15

S. cerevisiae

P22219

C. fasciculata

CFAC1_300029500

120

6.00E-27

L. major

LmjF.28.1760

102

3.00E-21

T. brucei

Tb927.11.9190

129

1.00E-29

T. cruzi

TcCLB.503715.40

59.7

2.00E-08

TcCLB.507809.119

53.5

4.00E-07

VPS38

S. cerevisiae

Q05919

None identified

VPS30

S. cerevisiae

Q02948

C. fasciculata
L. major
T. brucei
T. cruzi

ATG32

S. cerevisiae

P40458

None identified

TOR1

S. cerevisiae

P35169

C. fasciculata

CFAC1_280071400

627

0

C. fasciculata

CFAC1_290074900

617

0
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TOR2

S. cerevisiae

P32600

L. major

LmjF.36.6320

774

0

L. major

LmjF.34.4530

729

0

T. brucei

Tb927.10.8420

812

0

T. brucei

Tb927.4.420

644

0

T. cruzi

TcCLB.508231.30

844

0

T. cruzi

TcCLB.510689.40

723

0

Table 2 Genes involved in necroptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search. Orthologs among the four
trypanosomatid species were identified by TriTrypDB version 54.
GeneID
RIPK3

Organism
H. sapiens

UniProt ID
Q9Y572

Organism
None identified

RIPK1

H. sapiens

Q13546

None identified

MLKL

H. sapiens

Q8NB16

None identified

BIRC2

H. sapiens

Q13490

None identified

BIRC3

H. sapiens

Q13489

None identified

CYLD

H. sapiens

Q9NQC7

None identified

TNFA

H. sapiens

P01375

None identified

CASP8

H. sapiens

Q14790

None identified

NR2C2

H. sapiens

P49116

None identified

TRAF2

H. sapiens

Q12933

C. fasciculata

TriTrypDB ID

Score

E-value

CFAC1_220030700 48.9

9.00E-06

L. major

LmjF.07.0370

52.8

8.00E-07

T. brucei

Tb927.11.4660

46.2

8.00E-05

L. major
T. brucei
T. cruzi
TRAF5

H. sapiens

O00463

C. fasciculata

T. cruzi
Fas

H. sapiens

P25445

None identified

35
TRAILR2 H. sapiens

O14763

None identified

TNFR1

H. sapiens

P19438

None identified

TRAILR1 H. sapiens

O00220

None identified

TRADD

H. sapiens

Q15628

None identified

FADD

H. sapiens

O15519

None identified

NEMO

H. sapiens

Q9Y6K9

None identified

IF2B1

H. sapiens

Q9NZI8

C. fasciculata

CFAC1_200020600 172

1.00E-48

L. major

LmjF.29.1370

48.1

2.00E-05

T. brucei
T. cruzi
OPTN

H. sapiens

Q96CV9

None identified

JNK

H. sapiens

P45984

C. fasciculata

CFAC1_170008200 172

1.00E-48

L. major

LmjF.19.0180

173

3.00E-49

T. brucei

Tb927.10.14800

144

6.00E-39

T. cruzi

TcCLB.506211.180

177

1.00E-50

C. fasciculata

CFAC1_280073900 223

4.00E-69

L. major

LmjF.36.6470

225

2.00E-69

T. brucei

TcCLB.504167.30

233

1.00E-72

T. cruzi

Tb927.10.7780

225

1.00E-69

C. fasciculata

CFAC1_280024800 221

9.00E-68

L. major

LmjF.10.0490

267

2.00E-86

T. brucei

Tb927.8.3550

254

1.00E-81

T. cruzi

TcCLB.509475.10

142

4.00E-40

C. fasciculata

CFAC1_280024800 251

2.00E-80

L. major

LmjF.33.1380

256

6.00E-82

T. brucei

Tb927.10.12040

261

4.00E-84

T. cruzi

TcCLB.510123.20

248

5.00E-79

CFAC1_020008000 44.3

9.00E-05

ERK2

ERK1

p38

H. sapiens

H. sapiens

H. sapiens

P27361

P28482

Q15759

TLR4

H. sapiens

O00206

None identified

ZFP36

H. sapiens

P26651

C. fasciculata
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L. major

LmjF.35.1040

44.7

7.00E-05

T. brucei

Tb927.5.1580

49.7

2.00E-06

T. cruzi
DAPK1

H. sapiens

P53355

None identified

RAC1

H. sapiens

P63000

None identified

TCAM1

H. sapiens

Q8IUC6

None identified

ZBP1

H. sapiens

Q9H171

None identified

PLAT4

H. sapiens

Q9UL19

None identified

Table 3 Genes involved in apoptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search. MCA1-5 were represented
by Trypanosoma brucei. Orthologs among the four trypanosomatid species were identified by
TriTrypDB version 54.
GeneID
NFKB1

Organism
H. sapiens

UniProt ID
P19838

Organism
None identified

NFKB2

H. sapiens

Q00653

None identified

RelA

H. sapiens

Q04206

None identified

RelB

H. sapiens

Q01201

None identified

Rel

H. sapiens

Q04864

None identified

TLR3

H. sapiens

O15455

None identified

TNFL6

H. sapiens

P48023

None identified

TNF12

H. sapiens

O43508

None identified

TNR25

H. sapiens

Q93038

None identified

TNF10

H. sapiens

P50591

None identified

DEDD2

H. sapiens

Q8WXF8

None identified

CFLAR

H. sapiens

O15519

None identified

DIABLO

H. sapiens

Q9NR28

None identified

HTRA2

H. sapiens

O43464

None identified

APAF

H. sapiens

O14727

None identified

DFFB

H. sapiens

O76075

None identified

TriTrypDB ID

Score

E-value
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B2CL1

H. sapiens

Q07817

None identified

BCL2

H. sapiens

P10415

None identified

B2CL2

H. sapiens

Q92843

None identified

BAG1

H. sapiens

Q99933

None identified

BCL10

H. sapiens

O95999

None identified

BAX

H. sapiens

Q07812

None identified

BAK

H. sapiens

Q16611

None identified

BID

H. sapiens

P55957

None identified

BAD

H. sapiens

Q92934

None identified

BIK

H. sapiens

Q13323

None identified

BBC3

H. sapiens

Q9BXH1

None identified

APR

H. sapiens

Q13794

None identified

AVEN

H. sapiens

Q9NQS1

None identified

MYC

H. sapiens

P01106

None identified

14-3-3E

H. sapiens

P62258

C. fasciculata

CFAC1_130009500

263

9.00E-87

L. major

LmjF.11.0350

265

7.00E-88

T. brucei

Tb927.11.6870

243

8.00E-81

T. cruzi

TcCLB.506775.80

262

2.00E-86

C. fasciculata

CFAC1_010008300

344

2.00E-117

L. major

LmjF.35.1580

280

3.00E-91

T. brucei

None identified

T. cruzi

None identified

C. fasciculata

CFAC1_300060100

273

2.00E-88

L. major

LmjF.35.1580

295

2.00E-97

T. brucei

Tb927.6.940

0

0

T. cruzi

TcCLB.507537.40

384

2.00E-133

C. fasciculata

None identified

L. major

None identified

T. brucei

Tb927.6.930

0

0

MCA1

MCA2

MCA3

S. cerevisiae

T. brucei

T. brucei

Q08601

Q585F3

Q8T8E6
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MCA4

MCA5

T. brucei

T. brucei

Q8T8E5

Q8IEW1

T. cruzi

TcCLB.506531.50

C. fasciculata

None identified

L. major

None identified

T. brucei

Tb927.10.2440

T. cruzi

None identified

C. fasciculata

None identified

405

3.00E-141

705

0

L. major

EndoG

PHB

H. sapiens

H. sapiens

Q14249

P325232

T. brucei

Tb927.9.14220

781

0

T. cruzi

TcCLB.510759.160

481

7.00E-168

C. fasciculata

CFAC1_040014100

112

1.00E-27

L. major

LmjF.10.0610

105

3.00E-25

T. brucei

Tb927.8.4040

100

1.00E-23

T. cruzi

TcCLB.506867.10

103

1.00E-24

C. fasciculata

CFAC1_120028100

204

3.00E-65

L. major

LmjF.16.1610

204

9.00E-95

T. brucei

Tb927.8.4810

218

3.00E-70

T. cruzi

TcCLB.508837.120

214

1.00E-68

TMBIM1 H. sapiens

Q969X1

None identified

TMBIM2 H. sapiens

Q9BWQ8

None identified

TMBIM3 H. sapiens

Q7Z429

None identified

TMBIM4 H. sapiens

Q9HC24

None identified

TMBIM5 H. sapiens

Q9H3K2

C. fasciculata

CFAC1_210021700

61.6

2.00E-10

L. major

LmjF.24.1190

59.7

7.00E-10

T. brucei

Tb927.11.5820

64

2.00E-11

T. cruzi

TcCLB.503487.70

63.2

8.00E-11

TMBIM6 H. sapiens

P55061

None identified

EF1A1

P68104

C. fasciculata

CFAC1_090006400

694

0

L. major

LmjF.17.0080

720

0

T. brucei

Tb927.10.2090

739

0

H. sapiens
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T. cruzi
CASP7

H. sapiens

P55210

None identified

CASP3

H. sapiens

P70677

None identified

CASP6

H. sapiens

O08738

None identified

CASP10

H. sapiens

Q92851

None identified

DFFA

H. sapiens

O00273

None identified

DFFB

H. sapiens

O76075

None identified

NUMA1

H. sapiens

Q14980

None identified

SPTN1

H. sapiens

Q13813

None identified

TcCLB.511369.20

720

0

Table 4 Genes involved in parthanatos and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search. Orthologs in the four
trypanosomatid species were identified by TriTrypDB version 54.
GeneID
PARP1

Organism
H. sapiens

UniProt ID
P09874

Organism
C. fasciculata

TriTrypDB ID
CFAC1_020022700

Score
368

E-value
6.00E-114

L. major

None identified

T. brucei

Tb927.5.3050

410

4.00E-130

T. cruzi

CFAC1_020022700

362

1.00E-111

183

3.00E-48

AIF

H. sapiens

O95831

None identified

PARG

H. sapiens

Q86W56

C. fasciculata

CFAC1_300079100

L. major

None identified

T. brucei

Tb927.9.12810

191

2.00E-51

T. cruzi

TcCLB.507013.24

189

1.00E-50

C. fasciculata

CFAC1_230019300

42.7

4.00E-60

L. major

LmjF.33.1740

40.8

2.00E-05

T. brucei

None identified

T. cruzi

None identified

MIF

H. sapiens

P14174
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Table 5 Genes involved in ferroptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens proteins were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search.
GeneID
GPX4

FSP1

ACSL4

Organism
H. sapiens

H. sapiens

H. sapiens

UniProt ID
P36969

Q9BRQ8

O60488

Organism
C. fasciculata

TriTrypDB ID
CFAC1_290014000

Score
80.1

E-value
1.00E-17

L. major

LmjF.26.0820

78.6

1.00E-17

T. brucei

Tb927.7.1120

87.8

5.00E-21

T. cruzi

TcCLB.503899.110

84.3

7.00E-20

C. fasciculata

CFAC1_110012400

45.8

5.00E-05

L. major

LmjF.14.0440

55.1

5.00E-08

T. brucei

Tb927.7.4310

54.3

8.00E-08

T. cruzi

TcCLB.508089.50

60.8

8.00E-10

C. fasciculata

CFAC1_050011200

318

1.00E-96

L. major

LmjF.01.0520

316

6.00E-96

T. brucei

Tb927.9.4230

332

4.00E102

DHODH

H. sapeins

Q02127

T. cruzi

TcCLB.503575.50

315

9.00E-96

C. fasciculata

CFAC1_120013000

75.9

5.00E-15

L. major

LmjF.16.0530

71.2

2.00E-13

T. brucei

Tb927.5.3830

78.2

3.00E-14

T. cruzi

TcCLB.508375.50

73.6

5.00E-15

MBOA5

H. sapiens

Q6P1A2

None identified

ALOX15

H. sapiens

P16050

None identified

Q9UPY5

C. fasciculata

CFAC1_260058200

61.1

3.00E-09

L. major

LmjF.14.0320

50.4

3.00E-06

T. brucei

TcCLB.504213.110

57.4

2.00E-08

T. cruzi

Tb927.6.4660

51.1

4.00E-06

C. fasciculata

CFAC1_110019200

106

3.00E-24

L. major

LmjF.14.0910

138

4.00E-35

T. brucei

Tb927.7.4000

168

3.00E-45

T. cruzi

TcCLB.506659.30

139

1.00E-35

SLC7A11 H. sapiens

GSH

H. sapiens

P48637
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GBLB

H. sapiens

Q8NCG7

C. fasciculata

CFAC1_140007500

156

7.00E-38

L. major

LmjF.18.0160

156

7.00E-40

T. brucei

Tb927.10.13680

147

1.00E-46

T. cruzi

TcCLB.507993.180

139

5.00E-39

P62

H. sapiens

Q13501

None identified

NF2L2

H. sapiens

Q16236

None identified

TFR1

H. sapiens

P02786

None identified

Table 6 Genes involved in paraptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search. Orthologs between the 4
trypanosomatid species were identified by TriTrypDB version 54. Score and e values were
determined via TriTrypDB BLASTp parameters.
GeneID
CASP1

Organism
H. sapiens

UniProt ID
P29466

Organism
None identified

CASP4

H. sapiens

P49662

None identified

CASP5

H. sapiens

P51878

None identified

GSDMD

H. sapiens

P57764

None identified

TriTrypDB ID

Score

E-value

Table 7 Genes involved in pyroptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosomatids were determined via BLASTp search. Orthologs among the four
trypanosomatid species were identified by TriTrypDB version 54. Score and E-values were
determined via TriTrypDB BLASTp parameters.
GeneID
CASP1

Organism
H. sapiens

UniProt ID
P29466

Organism
TriTrypDB ID
None identified

CASP3

H. sapiens

P70677

None identified

CASP4

H. sapiens

P49662

None identified

CASP5

H. sapiens

P51878

None identified

ASC

H. sapiens

Q9ULZ3

None identified

AIM2

H. sapeins

O14862

None identified

GSDME

H. sapeins

O60443

None identified

Score E-value
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NLRC4

H. sapiens

Q9NPP4

None identified

MEFV

H. sapeins

O15553

None identified

NLRP3

H. sapiens

Q96P20

C. fasciculata

CFAC1_290010800

76.3

L. major

LmjF.26.0500

63.9

T. brucei

Tb927.7.1430

49.5

T. cruzi

TcCLB.503579.20

44.7

Table 8 Genes involved in oxeiptosis and their trypanosomatid homologs
Gene Identification numbers of relevant H. sapiens molecules were identified by UniProt and
homologs in trypanosome were determined via BLASTp search. Orthologs among the four
trypanosomatid species were identified by TriTrypDB version 54. Score and E-values were
determined via TriTrypDB BLASTp parameters.
GeneID
KEAP1

Organism
H. sapiens

PGAM5

H. sapiens

UniProt ID
Q14145

Organism
TriTrypDB ID
None identified

Score E-value

C. fasciculata

CFAC1_280045600 97.8

4.00E-23

L. major

LmjF.36.4070

100

8.00E-24

T. brucei

Tb927.11.10340

136

4.00E-37

T. cruzi

TcCLB.510283.40

125

8.00E-33
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4.2

Heat stress induces cell death
Parasites were subjected to thermal stress at various temperatures (38–50 ºC) for 1 hour

prior to staining with annexin-V and PI (Figure 3). Intuitively, there is a correlation between
temperature and cell death (Figure 2). As temperature rises, more cells begin to die. Cells begin
to die (~35% PI positive) around 40 ºC to 42 ºC, and PI positive cells occur 2.5 to 3-fold more
frequently (~35% of population) compared to cells treated at 38 ºC. At temperatures of 45 ºC,
cell death increases to 70%. These data suggest that, once temperatures become too high, cells
undergo unavoidable trauma and necrosis. Morphologically, cells begin to assume a teardropshape phenotype when stressed at 38 ºC. Higher temperatures lead to a shift to more rounded
cells with increased frequency of membrane rupture, cellular swelling, and changes in cellular
translucency.

Figure 2 Quantification of cells thermally stressed identify standard temperatures to
induce necrosis. Cells were treated at a range of temperatures for 1 hour and stained with PI.
Ppercentage of PI positive cells in a sample was determined. Data is presented as arithemetic
mean + S.E.M. p ≤ 0.05 (n=3, one-way ANOVA p=<0.05, unpaired T-test significance p=<0.05)
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Figure 3 Thermal stress causes morphological changes and induces cell death.
Representative slides from samples quantified in Figure 2 illustrating cellular response to thermal
stress as characterized by uptake of propidium iodide. Scale bars represent 10 µm.
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4.3

Hydrogen peroxide induces cell death

Parasites were exposed to increasing concentrations of H2O2 for 1 day prior to staining for cell
death via PI (Figure 4). Dead cells from all treatment groups were characterized by bright,
diffuse PI staining. The proportion of PI positive cells increased in a dose-dependent manner
(Figure 5). At 25 mM H2O2, cells begin to exhibit the teardrop phenotype that was seen with
cells exposed to temperature over 38 °C. At 50 mM H2O2, cells began to exhibit rounding, and
this morphology becomes increasingly prominent at higher concentrations. Parasites seem to be
able to tolerate H2O2 concentrations at or below 100 mM (≤20% PI+). However, once the dosage
reaches higher concentrations (250 and 500 mM), there is a 2 to 4-fold increase. Membrane
rupture is observed at 50 mM and above.

Figure 4 Quantification of cells oxidatively stressed present a dose-dependent response.
Cells were treated at a range of hydrogen peroxide for 1 day and stained with PI and
percentage of PI positive cells in a sample was determined. Data are presented as arithemetic
mean + S.E.M. (n=3, one-way ANOVA significance p=<0.05, unpaired T-test significance
p=<0.05)
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Figure 5 Hydrogen peroxide causes morphological changes and induces cell death.
Representative slides from samples quantified in figure 4 illustrating cellular response to
oxidative stress as characterized by uptake of propidium iodide. Scale bars represent 10 µm.
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4.4

Rotenone induces cell death
Parasites were treated with either 2 µM or 10 µM rotenone for 1 day prior to staining

dead cells with PI (Figure 5). There was a dose-dependent response observed, with a near 2-fold
increase in percentage of cells staining positive for PI (Figure 6). In contrast to cells treated with
hydrogen peroxide, rotenone treatment did not result in major changes in cell shape though PI
positive cells continued to be rounded. There was no evidence of membrane rupture. Of note, PI
staining in cells treated with 2 µM of rotenone was relatively dimmer and staining largely
retained the shape of the kinetoplast and nucleus. However, in the 10 µM of rotenone sample, PI
staining was much brighter and diffuse to the cell, with few instances of localized nuclear
staining.
✱✱✱✱

% PI Positive

40
30
20
10
0
0

2

10

[Rotenone] μM

Figure 6 Quantification of cells treated with rotenone present a dose-dependent
response. Cells were treated at 2 different doses of rotenone for 1 day and stained with PI and
percentage of PI positive cells in a sample was determined. Data is presented as arithemetic
mean + S.E.M. (n=3, one-way ANOVA significance p=<0.05, unpaired T-test significance
p=<0.05)
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Rotenone (µM)
2

10

PI

Phase Contrast

0

Figure 7 Rotenone causes morphological changes and induces cell death. Representative
slides from samples quantified in Figure 6 illustrating cellular response to rotenone treatment as
characterized by uptake of propidium iodide. Scale bars represent 10 µm.
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4.5

Starvation induces autophagic processes
Parasites were washed multiple times with sterile PBS to remove residual media and

either (1) nutrient starved in PBS or (2) serum starved in media not complemented with FBS.
After starvation, autophagic vacuoles were stained with MDC (Figure 7). Three days after
initiation of starvation, diffuse visualization of autophagic vacuoles were visible (data not
shown). By day 7, cells starved in PBS exhibit formation of multiple, brightly fluorescent,
autophagic vacuoles. In mammalian cells, a typical way to induce starvation is to deplete media
of serum. To mimic this, cells were depleted of FBS for 1 day. Indeed, these cells began to form
autophagic vacuoles (data not shown). To test a more time efficient method of autophagic
induction, cells were serum starved for 1 hour. After 1 hour, autophagic vacuoles were also seen
in the cells.
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MDC

PBS Starvation

Serum Depletion

Control

Phase Contrast

Figure 8 Serum depletion and nutrient starvation induces autophagic vacuole formation.
Cells were either grown in regular media without FBS for 1 hour or in PBS for 7 days and
stained with MDC. Arrows highlight clusters of autophagic vacuoles observed in single cells
(enlarged in insets).
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4.6

Cell death processes involve intranuclear DNA fragmentation

To test for changes in genomic DNA patterns, parasites were stressed and gDNA was separated
by electrophoresis (Figure 8). To mimic known inducers of necrosis in mammalian cells, cells
were treated with Triton X-100 (157). A sample was also heat shocked at 55 ºC for 4 hours to
also induce necrosis. Otherwise, treatments replicated previously established conditions
including 44 ºC for 1 day, 100 mM H2O2 for 1 day, serum starvation for 3 days, and 10 µM
rotenone. The distinctive laddering pattern seen in mammalian models is not apparent in C.
fasciculata under any stressors. Though bands are visible between 2000 and 3000 base pairs (bp)
for cells treated with rotenone, Triton X-100, heat shock, thermal stress, and hydrogen peroxide.
In addition to these, there are bands between 1500 and 2000 bp as well as above 3000 bp in the
serum starvation sample. Although necrosis is typically characterized by smearing of gDNA on
agarose gel, the supposed positive controls for necrosis resulted in presence of fragmented bands.
It is important to note that cell samples were not homogenous prior to gDNA extraction. That is,
only a small percentage of the pellet were dead cells.
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Figure 9 Variable changes in genomic pattern occur in response to cellular stress. Cells
were stressed with 10 µM rotenone (1 day), 44°C (1 day), serum starvation (3 days), or 100 mM
hydrogen peroxide in accordance to established conditions. In an effort to mimic necrotic
patterns as seen in mammalian systems, cells were also treated with 0.01% Triton X-100 (4
hours) and heat shock at 55°C (15 minutes). Ten micrograms of gDNA were separated on a 1%
agarose gel.
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4.7

Cellular stress induces nuclear morphology changes
To assess chromatin condensation arising from stress, parasites were either treated with 2

µM rotenone or 44 ºC thermal stress for 1 day prior to staining with Hoechst 33342 and PI
(Figure 9) (158,159). Cells treated with low-dose rotenone exhibited similar representation of
cell death as previously presented. Interestingly, these cells also had mild evidence of chromatin
condensation as determined by Hoechst staining, as characterized by dim fluorescence. Overall,
however, rotenone treated samples had notably less bright Hoechst staining than thermallystressed cells. PI positive cells also had brightly fluorescent Hoechst 33342.
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Hoechst 33342

PI

Thermal Stress

Rotenone

Control

Phase Contrast

Figure 10 Cell death can be characterzied by chromatin condensation. Cells were either
treated with 2 µM rotenone or at 44°C for 1 day and stained with Hoechst33342 to visualize
changes in DNA and PI to confirm cell demise. While Hoechst 33342 is permeant to the nuclear
and cell membrane, it only dimly stains cells at baseline (control group) but increases in
brightness in cells undergoing cell death. Arrows highlight an example of a PI-positive and
Hoechst 33342-positive cell in the rotenone treated group.
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4.8

Characterizing cell death by morphological changes
Since thermal stress is the simplest and most efficient method to induce cell death in C.

fasciculata, heat treatments were used to assess cell morphology more closely. Cells were
exposed to non-necrosis-inducing (38 ºC to 44 ºC) and necrosis-inducing temperatures (46 ºC to
50 ºC) for 1 hour prior to staining with annexin-V and PI (Figure 10). Notable patterns of cell
shape included the teardrop phenotype and cellular swelling and ballooning (Figure 10.D). The
teardrop phenotype develops possibly as a result of sublethal stress. These cells stain neither for
annexin-V nor PI. Cellular ballooning and swelling are described as enlarged, circular shape that
is different from that of rounded dying cells, immotile attached cells, and shrunken cells and
presumably present prior to membrane rupture. These cells either lacked staining of annexin-V
and PI or had very faint annexin-V staining and staining of the nuclear bodies. Rupture of the
plasma membrane was captured in multiple instances and is described as obvious displacement
of the perimeter of the cell (Figure 10.H). These instances are all characterized as diffuse
annexin-V staining and PI staining of the nuclear bodies. In a few instances in cells that appear to
be undergoing membrane rupture, there can be observed release of intracellular contents as
determined by both diffuse, dim “halo” staining of PI surrounding the cell as well as brightly
stained small, punctate specks (Figure 10.F).
Observation of the nucleus and kinetoplast with PI reveal instances of karyorrhexis
(fragmentation of the nucleus), nuclear dissolution, and nuclear condensation. Various cells
exhibited signs of nuclear fragmentation, described by more than two brightly stained bodies
(Figure 10.C) against a diffusely stained cell. This event may precede or follow nuclear
condensation, as described by larger and relatively brighter stained nuclear bodies (Figure 10.D).
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Finally, nuclear dissolution is evident and described as fluorescence of the entire cell body
without discernable nuclear bodies.
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Figure 11 Distinct patterns of nuclear morphology and cell shape are observed in dying
cells. Parasites were thermally stressed for 1 hour prior to staining with annexin-V and PI.
Patterns of morphological changes were captured and categorized by (B) baseline, non-stressed,
(C) nuclear fragmentation, (D) “teardropping” and ballooning, (E) DNA condensation, (F)
release of intracellular contents, (G) dissolution of the nuclear bodies, and (H) membrane
rupture.
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5

DISCUSSION

The concept of manipulating apoptosis and other regulated cell death pathways to combat
human pathologies and disease has yielded multiple advancements in modern medicine (160).
Since the observation of the apoptotic-like phenotype and autophagic process in trypanosomatids
(129,133,161), many questions have been raised regarding the potential applications of these
mysterious pathways. For example, trypanosomatids lack key molecules involved in RCD that
are present in their human hosts, suggesting that unique, undiscovered pathways could be
druggable targets (162). Furthermore, investigation of various organelle roles in cell death is
another area of interest. This can involve development of antiparasitic drugs or therapies that
prompt dysfunction of certain organelles such as the mitochondrion or endoplasmic reticulum
and thereby execute cell death (163). The biological relevance of the existence of these
pathways in unicellular organisms also remains a question. Thus far, various hypotheses have
been raised including altruism, maximizing biological fitness, population density control, and
evasion of the host immune system (131,133,164,165). Despite the scientific interest in PCD in
trypanosomes, there remains no comprehensive understanding of the molecular mechanisms
underlying these processes in these parasites. Furthermore, basic questions remain regarding
morphological characteristics of parasites undergoing programmed death and clarification of
these features beyond the ambiguity conveyed by the term “apoptotic-like phenotype”.
This study aimed to establish the means of utilizing C. fasciculata as a model organism to
study cell death processes in trypanosomatids. The comprehensive goal was to align the
morphological and genomic profile of C. fasciculata against known regulated cell death
pathways in other systems (Figure 12). Firstly, targeted investigation of C. fasciculata, T. brucei,
T. cruzi, and L. major genomes illustrates that key molecules involved in necroptosis, apoptosis,
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paraptosis, pyroptosis, and oxeiptosis do not exist in trypanosomatid genomes. In contrast,
trypanosomatids possess multiple key partners involved in ferroptosis and parthanatos.
Additionally, multiple ATG proteins responsible for important steps in autophagy in other
systems are present in trypanosomatids, consistent with prior studies that these parasites are
capable of engaging in autophagy (166-171). Furthermore, it is presented here that Crithidia
produce autophagic vacuoles in starvation conditions. These findings suggest that
trypanosomatids may have a divergent or unique mechanism of cell death and/or engage in
parthanatos or ferroptosis. In 2020, Teulière et al. investigated the characteristic genes associated
with various forms of RCD across mitochondriate protists including Trypanosoma and
Leishmania spp. (172). They concluded that presence of aerobic mitochondria was coupled with
the conservation of apoptosis-associated genes, supporting the endosymbiotic origin pathway.
They also suggest that selection for RCD pathways such as apoptosis are developmentally linked
to multicellularity. Kaczanowski et al. also used bioinformatics to suggest that apoptotic
mechanisms in protozoan parasites have diverged during evolution and existing homologs are
shared while other key proteins are “replaced” by uncharacterized molecules with similar
biochemical function (173). This supports the observations, both in published studies and this
project, that protozoal parasites can undergo apoptosis-like cell death but lack the molecules
normally thought to mediate these processes(129,174).
Secondly, exposure of C. fasciculata to various stressors result in induction of cell death,
but variations in the patterns suggest that multiple pathways for cell death exist. This may
resemble RCD in multicellular organisms in which the response to stress in cells depends on the
nature and duration of the exogenous factors of stressors (175). For example, cells respond
differentially towards DNA damage and oxidative stress. In this study, when parasites are
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thermally stressed below the temperatures of 46 °C, they display features of swelling, lysis,
chromatin condensation, DNA fragmentation, nuclear dissolution, and membrane rupture,
consistent with necroptosis. It has been suggested that thermal stress-induced death in
mammalian systems is necroptotic (176,177). Key molecules like necroptosome forming RIPK1RIPK3 and cell permeabilizing protein MLKL are absent in trypanosome genomes. In addition to
necroptosis, heat stress is also linked to various cell death pathways including apoptosis in
mammalian cells via irreversible damage to DNA, RNA, and proteins, cessation of the cell cycle,
and the relationship with increased ROS (178). Thermotolerance in these models is mediated by
heat shock proteins (HSP), a family of proteins that can protect cells from multiple stressors
including ROS and UV (179). HSPs play roles in various cell death pathways including intrinsic
and extrinsic apoptosis and necroptosis. HSPs can regulate stress kinases JNK and ERK, control
the release of cytochrome c, and block execution of apoptosis via caspase-3, Apaf-1, and
cytochrome c (180,181). HSPs are well conserved in trypanosomatids and have been implicated
in thermotolerance and survival in the host that occur as parasites adjust to temperature changes
that occur within the environment and during life cycles (182,183). Interestingly,
trypanosomatids also possess homologs for the MAPK stress pathway (ERK, JNK, and p38), and
studies have identified these proteins are critical for proliferation in vivo (184,185). It is evident
here that parasites may possess molecular mechanisms divergent from mammalian caspasecentralized apoptosis and necroptosis. These pathways could involve HSPs and possibly the
MAPK pathway, which can mediate cellular responses to thermal stress and lead to a cascade of
events that is “oncosis-like”, as characterized by cell swelling and membrane rupture.
Similar to mammalian systems, the mitochondria play a central role in RCD in
trypanosomatids (147,151,186), and investigation of mitochondrial activity and morphology can
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be informative in defining cell death pathways. For example, defects and dysregulation of
complex I of the electron transport change is linked to cell death in mammalian cell models. In
these models, rotenone inhibits oxidative phosphorylation activity of complex I, causing
incomplete electron transfer to oxygen (187). It therefore induces apoptosis via excess
production of mitochondrial ROS, opening of the mitochondrial permeability transition pore
(MTP), cytochrome c release, and caspase-3 execution (188,189). Rotenone inhibits complex I
activity in T. brucei (190). Crithidia fasciculata is also evidently sensitive to rotenone (Figure 7).
The drug induces cell death in C. fasciculata and is associated with what appears to be nuclear
fragmentation and chromatin condensation. However, these events are not accompanied with an
oncosis-like phenotype. Given trypanosomatids lack homologs for caspase-3, it is unlikely that
they share the same mitochondrial mechanism that is seen in the mammalian cell death pathway.
Interestingly, a transmembrane Bax inhibitor-1 motif 5 homolog (TMBIM5) is present in
trypanosomatids, suggesting a possible mechanism for executing cell death by other means. The
mammalian, TMBIM family consists of six proteins with different subcellular localizations who
are collectively involved in cellular Ca2+ signaling, cell survival, and stress resistance (191). In
mammals, TMBIM5 localizes to the mitochondrion and regulates cytochrome c release in the
context of activating intrinsic apoptosis (156). TMBIM5 is the sole representative of this protein
family in trypanosomatid genomes. Another interesting mitochondrial protein encoded in the
trypanosomatid genomes is endonuclease G, a protein that in mammals is involved in caspaseindependent apoptosis by degrading DNA via translocation to the nucleus as a consequence of
oxidative stress (192). Evaluation of the endoG homolog in T. brucei and Leishmania has proven
its functional capacity for intrinsic nuclease activity under oxidative or differentiation-related
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stress (193). It is possible a mitochondrial, “apoptotic-like” mechanism exists in trypanosomatids
and involves TMBIM5, endonuclease G, and cytochrome c.
Another mitochondrial-associated source of cell death is oxidative stress, which is
triggered by excess ROS production including H2O2, a byproduct of mitochondrial respiration
and superoxide dismutase activity. Excess levels of ROS, occurring when the cell’s antioxidant
and scavenging system are overwhelmed, causes irreversible damage to DNA and organelles,
and leads to regulated cell death. Cytochrome c is known to play a role in regulating H2O2
activity so that mitochondrial ROS levels are below the apoptosis-triggering threshold.
Cytochrome c has a ROS-scavenger role as in non-apoptotic conditions. Cytochrome c released
from the mitochondria caused by ROS production can actually have antioxidant properties (194).
In this study, Crithidia treated with external H2O2 displayed signs of induced-cell death in an
oncosis-like manner as characterized by nuclear dissolution, cellular swelling, membrane
rupture, and release of intracellular contents (Figure 5). Ferroptosis is a PCD pathway that is
triggered by failure of antioxidant systems and the subsequent accumulation of lipid peroxidation
following ROS/free radical-associated fatty acid radical production, as catalyzed by free iron.
Various antioxidant and ROS-scavenging properties have been identified in Leishmania and
Trypanosoma spp. including catalase, glutathione reductase, and glutathione peroxidase (195197). Trypanosomatids also possess genes encoding key proteins associated with ferroptosis
(GPX4, FSP1, DHODH, ACLS4, and SLC7A11). There has been limited investigation of
ferroptosis in trypanosomatids. In 2018 Bocacz observed ferroptosis-like cell death in T. brucei
and determined that tryparedoxin peroxidases, molecular relative of glutathione peroxidase 4,
play key role in the antioxidizing of lipid-derived hydroperoxides (198). Bogacz additionally
reported that the species is likely sensitive to iron-induced lipid peroxidation originating at the
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mitochondrial level, as obvious morphological and biochemical changes were noted in the
mitochondria (198). In mammalian cells, it was recently established that the protein
dihydroorotate dehydrogenase (DHODH) plays a key role in mitigating lipid peroxidation and
limits mitochondrially-mediated ferroptosis similar to that of the FSP1 and GPX4 (199).
Functional investigation of Trypanosoma DHODH has been performed, establishing that is a key
component of the pyrimidine biosynthetic pathway. However, the role of DHODH has not been
investigated with respect to ferroptosis. This protein and other molecules involved in the
ferroptosis system could possibly contribute to an oxidative stress-induced cell death pathway.
Trypanosomatids additionally possess homologs for PARP and PARG, key players in the
mitochondrial-associated, caspase-independent cell death pathway called parthanatos. This cell
death process is triggered by oxidative stress and genotoxic damage in mammalian systems,
resulting in DNA fragmentation and chromatin condensation (125). Investigation of PARP and
PARG in T. brucei highlighted changes in resistance to H2O2 and genotoxic stimuli, resulting in
cell death (200). Parthanatos is dependent on the apoptosis-inducing factor protein (AIF) in
mammalian models. This protein was not identified in the trypanosomatid genomes in the current
study. It is suspected that these proteins could have a mechanism different than mammalian
models, independent of AIF, in trypanosomatids alluding towards a unique regulated cell death
pathway.
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Figure 12 Crithidia fasciculata’s morphological profile of cell death is evidently unique
from currently described patterns. Literature review was conducted to determine known
characteristics of the PCD pathways of interest. Negative (-), red boxes indicate lack of that
particular feature. Positive (+), green boxes indicate presence of that particular feature. Question
marks (?) indicate that current understandings of this pathway have not reviewed these features.
In this study, multiple features were not investigated and therefore not determined (nd).

In conclusion, it is evident that trypanosomatids are capable of engaging in a regulated
cell death pathway, characterized by differential changes in the cell in response to various
stressors. When comparing the observed nuclear and morphological changes as well as the
homology profile of C. fasciculata with that already known in other species, it is evident that
trypanosomatids possess unique pathways of regulated cell death inaccurately referred to as
“apoptosis-like”. It is clear that the parasites can engage in at least two distinct pathways, one
characterized by swelling, membrane rupture, and release of intracellular contents, and one
without these characteristics. This study highlights multiple avenues of mystery that require
further investigation to better understand PCD in these influential parasites.
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APPENDICES
Appendix A
Table 9 Putative homologs identified in trypanosomatid genomes and associated
functions defined in other systems
Gene and
Protein
Function
synonyms
VPS34

ATG1
(ULK1)

Phosphatidylinositol 3-kinase VPS34

Serine/threonine-protein kinase ATG1

cytoplasm to vacuole transport (Cvt) and VPS34
PI3-kinase complex I autophagy
recruits ATG8-phosphatidylinositol conjugate and
ATG12-ATG5 conjugate to autophagosomal
structure
Cvt, required for formation of autophagosomes

VPS53

Vacuolar protein sorting-associated
protein 53

ATG20,
CVT20

Autophagy-related protein 20

nucleophagy, mitophagy, endoplasmic reticulum
(ER) degradation
part of the GARP complex involved in retrograde
transport from early to late endosomes to the
trans-Golgi network
Cvt, pexophagy, mitophagy

ATG24,
SNX4,
CVT13

Sorting nexin-4

survival of cells during severe ER stress
mitophagy and pexophagy

ATG3

Autophagy-related protein 3

ATG4

Cysteine protease ATG4

retrieval of late-Golgi SNARES from post-Golgi
endosomes for Cvt
E2 conjugating enzyme required for Cvt and
autophagy, nucleophagy, mitophagy
covalent binding activity of
phosphatidylethanolamine to Gly of ATG8
CvT and autophagy, nucleophagy, mitophagy
cleaves C-terminal AA of ATG8

ATG7,
CVT2

Ubiquitin-like modifier-activating
enzyme ATG7

ATG8,
CVT5

Autophagy-related protein 8

ATG21,
CVT21

Autophagy-related protein 21

ATG8-PE deconjugation
activating enzyme involved in 2 ubiquitin-like
systems required for Cvt and autophagy
activates ATG12 to conjugate with ATG5 and
ATG8 to conjugate with
phosphatidylethanolamine
Cvt and autophagosome formation, nucleophagy,
mitophagy
mediates delivery of vesicles and autophagosomes
-Cvt, vesicle formation, mitophagy
binding phosphatidylethanolamine to ATG8 and
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ATG26
ATG9,
CVT7
ATG18,
CVT18

Sterol 3-beta-glucotransferase
Autophagy-related protein 9

recruiting ATG to pre-autophagosomal structure
(PAS)
synthesis of sterol glucoside membrane lipids
Cvt vesicle formation, mitophagy

Autophagy-related protein 18

organization of PAS, recruits ATG23
proper vacuole morphology
osmotically-induced vacuole fragmentation

VPS15

Serine/threonine-protein kinase VPS15

VPS30,
ATG6

Beclin-1-like protein

TOR1,
TOR2

Serine/threonine-protein kinase TOR1,
TOR2

TRAF2

TNF receptor-associated factor 2

TRAF5

TNF receptor-associated factor 5

Cvt vesicle formation, pexophagy
Cvt and autophagy
recruits ATG-phosphatidylinositol and ATG12ATG5 conjugates to PAS
limits pathogen-associated cell death response and
autophagic activity
vacuolar protein sorting
regulates multiple cellular processes controlling
cell growth in response to nutrients
regulates nutrient transport and autophagy
regulates activation of NF-kappa-B and JNK and
regulates cell survival and apoptosis
inhibits necroptosis signaling
links TNF receptors to signaling pathways
mediates NFkB and JNK

IF2B1,
ZBP1
JNK,
MAPK8

Insulin-like growth factor 2 mRNAbinding protein 1
Mitogen-activated protein kinase 8

inhibits necroptosis and protects from apoptosis
senses endogenous Z-form nucleic acids and
triggers RIPK3-dependend necroptosis
stimulated by extracellular cytokines or physical
stress to activate the stress-associated/JNK
pathway
regulates expression of genes and pro- and antiapoptotic proteins

ERK2,
MAPK1

Mitogen-activated protein kinase 1

regulates TNF- and TLR’s-mediated necroptosis
essential part of MAP kinase signal transduction
pathway and MAP/ERK cascade

ERK1,
MAPK3

Mitogen-activated protein kinase 3

involved in the activation of necroptosis and the
mediating necrostatin-1

P38,
MAPK11

Mitogen-activated protein kinase 11

regulates a broad range of cellular processes
including proliferation, differentiation, and cell
cycle progression
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ZFP36,
TTP

mRNA decay activator protein ZFP36

YWHA,
1433

14-3-3 protein

MCA1

Metacaspase-1

MCA2

Metacaspase-2

MCA5

Metacascpase-5

MCA3

Metacaspase-3

MCA4

Metacaspase-4

ENDOG
PHB

Endonuclease G
Prohibitin

important modulators of gene expression and
inflammatory responses
suppresses TNF-alpha by stimulated AU-rich
element-mediated TNF-alpha mRNA decay
stabilizes RIP1 and promotes ripoptosome
assembly
inhibits apoptosis and alleviates cellular stress
sequesters BAD and FKHRL1 to cytoplasm
mediates cell death triggered by oxygen stress, salt
stress, and chronological age
cysteine protease that cleaves after arginine or
lysine
may play a role in cell cycle G1/S transition of
parasites
plays a role in parasite bloodstream form growth
and parasite virulence
fragments DNA during apoptosis
broad range of cellular functions determined by
subcellular localization
translocates to mitochondrial or nucleus under
apoptotic signals, important part of mitochondrial
apoptotic pathway
mitochondrial tubular network and cristae
organization

TMBIM5,
GHITM

Growth hormone-inducible
transmembrane protein

DLC1,
EF1A1

Rho GTPase-activating protein 7

apoptotic release of cytochrome c
terminates downstream signaling of small
GTPases

PARP

Poly ADP-ribose polymerase 1

induces mitochondrial apoptosis
mediates parthanatos when over-activated in
response to genomic stress

PARG
MIF
GPX4

FSP1,
AIFM2

Poly ADP-ribose glycohydrolase
Macrophage migration inhibitory
factor
Phospholipid hydroperoxide
glutathione peroxidase

Ferroptosis suppressor protein 1

synthesizes PAR, causing nuclear translocation of
AIF
-involved in various functions, namely DNA
repair
regulates PAR after synthesis by PARP
PARP1-dependent AIF-associated nuclease that
cleaves genomic DNA into fragments
antioxidant peroxidase that reduces phospholipid
hydroperoxide
protects cells from oxidative damage, required to
prevent ferroptosis
NAD(P)H-dependent oxidoreductase involved in
oxidative stress response, prevents lipid oxidative
damage, suppressing ferroptosis
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DHODH,
PYRD

Dihydroorotate dehydrogenase

ACSL4

Long-chain-fatty-acid—CoA ligase 4

SLC7A11
xCT
PGAM5

Cystine/glutamate transporter

NLRP3

Serine/threonine-protein phosphatase
PGAM5

NACHT, LRR, and PYD domainscontaining protein 3

mitochondrial protein associated with the ETC,
responsible for regulating bioenergetics, cell
proliferation, ROS production, and apoptosis
catalyzes conversion of long-chain fatty acids to
acyl-CoA for synthesis of lipids and degradation
via beta-oxidation, essential for ferroptosis
execution
imports cystine for glutathione biosynthesis and
antioxidant defense
substrate for KEAP1-depentent ubiquitin ligase,
forms tri-partite complex with KEAP1 and NRF2
key downstream effector of oxeiptosis pathway
-dephosphorylates and activates MAP3K5 kinase
central mediator for programmed necrosis by
TNF, ROS, and calcium ionophore
initiates formation of inflammasome polymeric
complex in response to damage signals to initiate
pyroptosis

